• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Submit An Op-Ed

HIT Consultant contributors are thought-leaders in the healthcare technology community who bring deep insight and knowledge to our content and platform.

If you are interested in submitting an op-ed for publication, please see the guidelines below. 

Submit to: submissions@hitconsultant.net.

You can also find examples of our op-eds in our opinion section. 

Submitting Op-Ed Guidelines

– All op-eds submitted for publication at HIT Consultant should be the guest author’s original work content should not be published anywhere else.

– Op-eds should be between 750– 1,500 words. Longer posts will be accepted pending content relevance.

– Op-eds should be healthcare technology-related. 

– HIT Consultant does not accept self-promotional articles or advertorials. These types of works will automatically be rejected. Please refrain from mentioning your company or products in the post. Contributed articles are for the purpose of showcasing thought leadership within the industry. Company mentions will either result in a rejection or being removed from the submission before publication.

– Please include a short 1 to 2-line author bio and company profile. This includes title and any social media profiles. Include a headshot for image next to byline.
Include any high-resolution images/graphs/figures that support the article.

– Please cite sources used and provide proper attribution especially when citing statistics and quotes.

– Articles should be reviewed for clarity, spelling, punctuation and grammar prior to submission.

– All op-eds will be reviewed by HIT Consultant staff prior to publication.

– HIT Consultant reserves the right to revise any contributed content to meet the needs of the readers.

– All contributed articles are promoted via HIT Consultant social media outlets.

PLEASE NOTE: HIT Consultant cannot respond to every submission sent in. If your article is considered for publication, a member of the editorial staff will follow up with a publication date. 

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |